Immunobiologicals in dermatology

Silva, Dimitri Luz Felipe da; Secamilli, Elisa Nunes; Beleli, Mariana Valbon; Massuda, Juliana Yumi; Franca, Andrea F.E.C.; Magalhães, Renata F.

Silva, Dimitri Luz Felipe da; Secamilli, Elisa Nunes; Beleli, Mariana Valbon; Massuda, Juliana Yumi; Franca, Andrea F.E.C.; Magalhães, Renata F..

Silva, Dimitri Luz Felipe da; Universidade Estadual de Campinas. Hospital de Clínicas. Campinas. BR
Secamilli, Elisa Nunes; Universidade Estadual de Campinas. Hospital de Clínicas. Campinas. BR
Beleli, Mariana Valbon; Universidade Estadual de Campinas. Hospital de Clínicas. Campinas. BR
Massuda, Juliana Yumi; Universidade Estadual de Campinas. Hospital de Clínicas. Campinas. BR
Franca, Andrea F.E.C.; Universidade Estadual de Campinas. Hospital de Clínicas. Campinas. BR
Magalhães, Renata F.; Universidade Estadual de Campinas. Hospital de Clínicas. Campinas. BR

An. bras. dermatol ; 97(3): 275-283, 2022. tab

Article in English | LILACS-Express | LILACS | ID: biblio-1383585

ABSTRACT

ABSTRACT

Abstract Immunobiologicals are a reality in current clinical practice and have increasingly gained space in the inflammatory disease scenario, especially in dermatology, with approved drugs for psoriasis, atopic dermatitis, and hidradenitis suppurativa, in addition to many others undergoing study. It is important for dermatologists to have knowledge of the medications approved in Brazil, for the best management of dermatoses, in addition to the fact that they represent hope for improvement in patients with chronic diseases.

Arthritis, psoriatic; Dermatitis, atopic; Hidradenitis suppurativa; Psoriasis

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Language: English Journal: An. bras. dermatol Journal subject: Dermatology Year: 2022 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Estadual de Campinas/BR

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google